CIMC Group Announces 2024 Interim Results

Financial Highlights RMB million For the 6 months ended 30 June   2024 2023 Change 24Q2 24Q1 Change Revenue 79,115 60,574 30.61% 46,672 32,443 43.86% Operating profit 2,115 1,645 28.60% 1,708 407 319.8% Net profit 1,395 990 40.85% 1,177 218 440.12% Net profit attributable tothe Company and other equity holders of the Company 866 399 […]

Pioneering Green Growth with Technological Innovation and Accelerating Global Strategy

HONG KONG, Aug 29, 2024 – (ACN Newswire via SeaPRwire.com) – Tianneng Power International Company Limited (the “Company”, together with its subsidiaries, collectively the “Group” or “Tianneng”) (stock code: 00819.HK), a leading company in China’s new energy battery industry, announced its interim results for the six months ended 30 June 2024 (the “Reporting Period”). In the […]

Banle Group Expands Global Port Coverage to Over 60 Ports

HONG KONG, Aug 29, 2024 – (ACN Newswire via SeaPRwire.com) – CBL International Limited (the “Company” or “CBL”) (NASDAQ: BANL), the listing vehicle of Banle Group (“Banle” or “the Group”), a reputable marine fuel logistic company in the Asia-Pacific region, proudly announces a significant milestone by expanding its global port coverage to over 60 ports […]

Sunshine Insurance Announces 2024 Interim Results

2024 Interim Results Highlights: – GWPs increased by 12.8% YoY to RMB76.46 billion;– Insurance revenue increased by 4.4% to RMB31.49 billion;– Net profit attributable to equity owners of the parent increased by 8.6% to RMB3.14 billion;– Embedded value was RMB112.64 billion, up 8.2% from the end of last year on a comparable basis;– The annualised […]

Hitachi High-Tech and Gencurix entered a partnership in cancer molecular diagnostics business

Hitachi High-Tech Corporation (“Hitachi High-Tech”) and Gencurix, Inc. (“Gencurix”) have entered a strategic partnership (the Partnership) in the field of cancer molecular diagnostics(1). The Partnership aims to develop a testing service for the cancer molecular diagnostics by combining Hitachi High-Tech’s core expertise in R&D and manufacturing of in vitro diagnostic products and digital technology, and […]